Services
Occupational Health
Workplace wellbeing, done right. Tailored services that boost safety and meet your needs.
For your business
Detect
For your patients
Diagnose
From concept to manufacture
Discover
Research & Development
From concept to creation. Discover how we can turn your ideas into diagnostic solutions.
Dual detection of occult blood and transferrin in stool samples.
The Transferrin & Faecal Occult Blood Rapid Test Cassette is a qualitative immunoassay designed to detect both human haemoglobin and transferrin in stool specimens. Combined testing improves the detection of gastrointestinal bleeding from both upper and lower regions of the GI tract.
This enhanced screening approach supports early identification of conditions associated with colorectal and upper gastrointestinal cancers.
Product and testing parameters
*MOQ 500 - contact a member of the team for more information
Key benefits
Dual detection of FOB and transferrin
Enhanced sensitivity for GI bleeding
Rapid point‑of‑care results
No dietary restrictions required
Non‑invasive stool‑based screening
Suitable for professional oncology screening
Directions for use: collect faecal specimens
Directions for use: process faecal specimens
Directions for use: running the test
Directions for use: reading the results
Interpretation of results
About Transferrin & Faecal Occult Blood (FOB)
Transferrin is more stable than haemoglobin in the digestive tract, making it a useful additional marker for detecting upper gastrointestinal bleeding. Combined FOB and transferrin testing provides broader screening coverage in oncology pathways.
What does the Transferrin & Faecal Occult Blood test detect?
The test detects human haemoglobin (faecal occult blood) and human transferrin in stool samples. Together, these biomarkers help identify gastrointestinal bleeding that may be associated with colorectal cancer, upper GI malignancies or other gastrointestinal conditions.
Why does this test include transferrin as well as faecal occult blood?
Transferrin is more stable than haemoglobin as it passes through the digestive tract. Its inclusion improves the detection of bleeding originating from the upper gastrointestinal tract, providing broader screening coverage than FOB testing alone.
How is this combined test used in screening pathways?
Combined FOB and transferrin testing supports enhanced gastrointestinal screening, particularly in cases where upper GI bleeding may be suspected or where increased sensitivity is required for early assessment.
Is a positive result diagnostic of cancer?
No. A positive result indicates the detection of blood and/or transferrin in the stool but is not diagnostic of cancer. Further clinical investigation is required to determine the underlying cause.
Are dietary restrictions required before using this test?
No dietary restrictions are required. The test is specific to human proteins, minimising interference from food sources or dietary blood.
Who is this test intended for?
This test is intended for professional use only within oncology and gastrointestinal screening programmes and should be used alongside clinical assessment and confirmatory diagnostics.
Dr Rahul Batra, Guy’s and St Thomas Hospital
SureScreen lateral flow testing provided a result at the bedside within 10 mins which, when positive for symptomatic patients, enabled movement into a COVID-19 bay without delay.
Cordell Health
SureScreen Diagnostics are very efficient in their responses when ordering consumables, offer excellent advice when we have drug queries and you have a user-friendly portal.
Mac Clinical Research
Fantastic company! Excellent helpful customer service, efficient ordering, and delivery process.
Premiership Rugby
Premiership Rugby and our Clubs have been working with SureScreen Diagnostics since March 2021. We have always received professional and prompt responses to all of our queries and orders.
Endovab Care
We have close and swift access to SureScreen Account Managers and received prompt answers to questions and impeccable deliveries. We are very satisfied with product quality and deliveries.